El-Dorado Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.96 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.84 M
- Revenue Growth 29.05%
- Profit Growth 28.36%
- Ebitda 103.47%
- Net Worth 17.70%
- Total Assets 22.21%
About El-Dorado Biotech
El-Dorado Biotech Private Limited (EBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 December 2002 and has a history of 22 years and two months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.96 M.
The company currently has active open charges totaling ₹4.84 M.
Vandana Joshi and Vinay Joshi serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH2002PTC138220
- Company No.
138220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at El-Dorado Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Joshi  | Director | 11-Dec-2002 | Current |
| Vandana Joshi | Director | 15-Dec-2005 | Current |
Financial Performance of El-Dorado Biotech.
El-Dorado Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.05% increase. The company also saw a substantial improvement in profitability, with a 28.36% increase in profit. The company's net worth Soared by an impressive increase of 17.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of El-Dorado Biotech?
In 2021, El-Dorado Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
El-Dorado Pharma Private LimitedVandana Joshi and Vinay Joshi are mutual person
- El-Dorado Social Foundation
Vandana Joshi and Vinay Joshi are mutual person
Charges (Loans)
₹4.84 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2024 | Others | ₹4.84 M | Open |
How Many Employees Work at El-Dorado Biotech?
Unlock and access historical data on people associated with El-Dorado Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of El-Dorado Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped El-Dorado Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.